Skip to main content
. 2019 Mar 1;46(1):22–29. doi: 10.5653/cerm.2019.46.1.22

Table 3.

IVF cycle characteristics and outcomes with subjects divided into four groups by maternal and paternal age

Variable Group 1 Group 2 Group 3 Group 4 p-value
No. of cycles 58 12 37 68
Average maternal age (yr) 32.0 ± 1.8 33.42 ± 0.8 36.9 ± 1.9 39.3 ± 2.4 < 0.001
Average paternal age (yr) 34.5 ± 2.4 40.83 ± 2.4 36.6 ± 1.9 43.4 ± 4.0 < 0.001
Average difference: paternal–maternal age (yr) 2.6 ± 2.2 7.42 ± 2.5 –0.3 ± 2.7 2.9 ± 2.1 < 0.001
BMI (kg/m2) 21.1 ± 3.6 22.48 ± 4.2 21.1 ± 2.6 21.1 ± 3.1 0.55
No. of previous IVF attempts 2.0 ± 1.3 2.83 ± 5.7 2.1 ± 1.4 2.9 ± 2.1 0.11
AMH concentration (ng/mL) 4.7 ± 3.3 4.31 ± 2.5 4.1 ± 3.4 5.3 ± 4.9 0.80
Antral follicle count 16.3 ± 7.4 13.83 ± 11.0 13.4 ± 6.5 14.2 ± 9.5 0.18
Basal E2 concentration (pg/mL) 44.3 ± 24.8 35.37 ± 13.7 43.4 ± 17.3 52.8 ± 36.9 0.22
Basal LH concentration (mIU/mL) 5.0 ± 2.0 6.68 ± 3.5 5.2 ± 2.6 5.3 ± 3.0 0.30
Basal FSH concentration (mIU/mL) 6.5 ± 2.4 6.67 ± 1.3 6.8 ± 2.2 6.4 ± 2.4 0.69
E2 concentration on hCG day (pg/mL) 3,614.2 ± 1,802.8 4,416.1 ± 2,502.6 3,332.3 ± 1,993.6 3,566.8 ± 2,714.5 0.67
LH concentration on hCG day (mIU/mL) 2.9 ± 2.4 3.84 ± 3.3 2.3 ± 2.3 3.7 ± 4.2 0.38
Progesterone concentration on hCG day (ng/mL) 1.0 ± 0.5 1.12 ± 0.6 0.9 ± 0.7 1.0 ± 0.5 0.95
Average endometrial thickness on hCG day (cm) 1.0 ± 0.2 1.05 ± 0.3 1.0 ± 0.2 0.9 ± 0.2 0.07
No. of total oocytes 18.6 ± 10.9 18.5 ± 8.6 15.9 ± 7.4 15.7 ± 11.0 0.29
Fertilized oocyte (%) 67.7 70.7 71 74.3 0.39
No. of blastocysts analyzed for PGS 210 36 129 196 -
Euploid blastocyst 47.6 (100/210) 47.2 (17/36) 35.7 (46/129) 28.6 (56/196) 0.001
Abortion rate 2.4 (1/41) 0 (0/8) 20.0 (4/20) 18.4 (7/38) -
Clinical pregnancy rate 51.2 (21/41) 37.5 (3/8) 65.0 (13/20) 44.7 (17/38) 0.44

Values are presented as mean±standard deviation or percent (number) unless otherwise indicated. Group 1: maternal age (MA) <35 year, paternal age (PA) ≤38 year; Group 2: MA <35 year, PA >38 year; Group 3: MA ≥35 year, PA ≤38 year; Group 4: MA ≥35 year, PA >38 year.

IVF, in vitro fertilization; BMI, body mass index; AMH, anti-Müllerian hormone; E2, estradiol; LH, luteinizing hormone; FSH, follicle-stimulating hormone; hCG, human chorionic gonadotropin; PGS, preimplantation genetic screening.